We are live on
!
Find out more
PFO
Pathstone Family Office Portfolio holdings
AUM
$13.1B
1-Year Est. Return
21.02%
This Fund
S&P 500
This Quarter
Est. Return
+0.72%
1 Year Est. Return
+21.02%
3 Year Est. Return
+39.27%
5 Year Est. Return
+59.47%
10 Year Est. Return
+236.85%
AUM
$768M
AUM Growth
-$80.1M
(-9.5%)
Cap. Flow
-$27.1M
Cap. Flow
% of AUM
-3.53%
Top 10 Holdings %
Top 10 Hldgs %
60.99%
Holding
740
New
85
Increased
91
Reduced
143
Closed
103
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$1.75M |
| 2 |
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
|
+$1.16M |
| 3 |
Lyft
LYFT
|
+$989K |
| 4 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$721K |
| 5 |
Xylem
XYL
|
+$522K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royal Bank of Canada
RY
|
+$11.3M |
| 2 |
iShares Russell 1000 ETF
IWB
|
+$9.09M |
| 3 |
CarMax
KMX
|
+$5.75M |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$2.77M |
| 5 |
Microsoft
MSFT
|
+$2.09M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 25.36% |
| 2 | Technology | 10.73% |
| 3 | Consumer Discretionary | 9.26% |
| 4 | Communication Services | 3.87% |
| 5 | Industrials | 3.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Intel
INTC
$461B
| $435K | 0.06% |
8,451
-26,601
| -76% | -$1.31M |
|
102
GE Aerospace
GE
$379B
| $432K | 0.06% |
9,682
-3,990
| -29% | -$188K |
|
103
US Bancorp
USB
$99B
| $431K | 0.06% |
7,778
-7,850
| -50% | -$424K |
|
104
iShares MSCI Pacific ex Japan ETF
EPP
$2.22B
| $419K | 0.05% |
9,373
| – | – |
|
105
iShares MSCI Emerging Markets ETF
EEM
$28.9B
| $417K | 0.05% |
10,200
-10,550
| -51% | -$436K |
|
106
Jacobs Solutions
J
$16.3B
| $416K | 0.05% |
5,500
+1,109
| +25% | +$79.3K |
|
107
Boston Scientific
BSX
$71.6B
| $411K | 0.05% |
10,091
-5,000
| -33% | -$212K |
|
108
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.46B
| $406K | 0.05% |
8,290
| – | – |
|
109
PepsiCo
PEP
$190B
| $370K | 0.05% |
2,698
-2,075
| -43% | -$276K |
|
110
Southern Company
SO
$108B
| $361K | 0.05% |
5,853
-400
| -6% | -$23.2K |
|
111
State Street SPDR S&P Dividend ETF
SDY
$23.5B
| $359K | 0.05% |
3,495
+1,060
| +44% | +$107K |
|
112
Liberty Broadband Class C
LBRDK
$4.85B
| $354K | 0.05% |
3,383
+616
| +22% | +$64.3K |
|
113
iShares Russell 1000 Value ETF
IWD
$82.5B
| $339K | 0.04% |
2,650
+56
| +2% | +$7.12K |
|
114
MSC Industrial Direct
MSM
$6.99B
| $338K | 0.04% |
4,662
| – | – |
|
115
Liberty Media Series C
FWONK
$24.5B
| $320K | 0.04% |
7,936
+2,004
| +34% | +$77.8K |
|
116
iShares MSCI USA Quality Factor ETF
QUAL
$47B
| $320K | 0.04% |
3,464
+3,334
| +2,565% | +$307K |
|
117
Oracle
ORCL
$405B
| $315K | 0.04% |
5,705
-11,794
| -67% | -$652K |
|
118
Palo Alto Networks
PANW
$280B
| $306K | 0.04% |
9,000
| – | – |
|
119
Eli Lilly
LLY
$998B
| $301K | 0.04% |
2,688
-3,950
| -60% | -$440K |
|
120
Abbott
ABT
$185B
| $278K | 0.04% |
3,336
-7,327
| -69% | -$623K |
|
121
Wells Fargo
WFC
$264B
| $276K | 0.04% |
5,446
-12,200
| -69% | -$575K |
|
|
HI
122
DELISTED
Hillenbrand
HI
| $272K | 0.04% |
8,803
| – | – |
|
123
Mohawk Industries
MHK
$7.94B
| $267K | 0.03% |
2,154
+368
| +21% | +$47.2K |
|
124
Vanguard Morningstar Mid-Cap Value ETF
VOE
$23.8B
| $260K | 0.03% |
2,303
-8
| -0.3% | -$889 |
|
|
SCHW
125
Charles Schwab
SCHW
$183B
| $257K | 0.03% |
6,148
+97
| +2% | +$3.92K |
|
Similar funds
CG
API
TA
SCH
PWAG
CS
IWP
MAM
Pathstone Family Office's Q3 2019 Portfolio in Review
As of Q3 2019, Pathstone Family Office held 740 positions worth $768M, down 9.5% from $848M the previous quarter. Its ten largest holdings account for 61% of the portfolio.
Pathstone Family Office withdrew a net $27.1M in Q3 2019, closing 103 positions and reducing 143 holdings. Its most notable exit was UroGen Pharma, an estimated $1.47M position sold in full.
By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 25% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Pathstone Family Office opened a new position in Xylem worth $529K.
- Pathstone Family Office's largest Q3 2019 buy was Xylem: 6,643 shares worth $529K.
- Pathstone Family Office added most to Vanguard S&P 500 ETF in Q3 2019, an estimated $1.75M increase.
- Pathstone Family Office's biggest Q3 2019 reduction was Royal Bank of Canada, cutting an estimated $11.3M.
- Pathstone Family Office fully exited UroGen Pharma in Q3 2019, selling an estimated $1.47M.
- Pathstone Family Office's ten largest holdings make up 61% of its $768M portfolio in Q3 2019.
- Pathstone Family Office opened 85 new positions and closed 103 in Q3 2019.
- Pathstone Family Office's portfolio value fell 9.5% quarter-over-quarter to $768M.
Based on Pathstone Family Office's 13F filing for Q3 2019, filed 13 Nov 2019.